Tech Company Financing Transactions
Tyra Biosciences Funding Round
Tyra Biosciences, based in Carlsbad, raised $200 million in investment from RA Capital Management, 5AM Ventures and Boxer Capital.
Transaction Overview
Company Name
Announced On
2/2/2024
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Undisclosed
Investors
RA Capital Management (Lead Investor)
Boxer Capital (Sid Subramony)
Proceeds Purpose
TYRA intends to use the net proceeds from the PIPE to advance the clinical development of TYRA-300 and TYRA-200, to advance its preclinical programs, and for drug discovery, working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2333 State St. 201
Carlsbad, CA 92008
USA
Carlsbad, CA 92008
USA
Phone
Undisclosed
Website
Email Address
Overview
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Harris
Browse more venture capital transactions:
Prev: 2/2/2024: Myavana venture capital transaction
Next: 2/2/2024: Cohere Health venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs